Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2007-10-16
pubmed:abstractText
Modification of the C-1 ketone of salvinorin A (2a) produces analogues with opioid antagonist properties. Of particular significance is the finding that 1-deoxo-1,10-dehydrosalvinorin A (11a) is a moderately potent antagonist at all three opioid receptor subtypes, and that herkinorin (2b), a mu agonist, is converted to a weak antagonist by removal of the C-1 ketone (3b and 11b). These observations suggest that the ketone of 2b is a key structural feature responsible for mu agonist activity.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-10516640, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-10822058, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-10963753, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-11714863, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-11807176, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-12192085, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-12676881, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-14718611, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-15380207, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-15658846, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-15987194, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16033256, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16415903, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16441078, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16621556, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16777411, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-16792410, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-17060492, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-17090705, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-17222056, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-17303418, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-2549665, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-6118865, http://linkedlifedata.com/resource/pubmed/commentcorrection/17904842-7723747
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6111-5
pubmed:dateRevised
2010-8-9
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.
pubmed:affiliation
Holden Laboratories, Carmel, CA 93923, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural